Provided by Tiger Trade Technology Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C

0.0030
0.0000
Volume:- -
Turnover:- -
Market Cap:204.01K
PE:-0.01
High:0.0030
Open:0.0030
Low:0.0030
Close:0.0030
52wk High:0.1760
52wk Low:0.0030
Shares:68.00M
Float Shares:68.00M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4722
ROE:-53.85%
ROA:-23.19%
PB:0.01
PE(LYR):- -

Loading ...

Jan 04, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2022

Major Issues Report

Form 8-K - Current report
Nov 14, 2022

Major Issues Report

Form 8-K - Current report
Nov 14, 2022

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2022

Correspondence

Form CORRESP - Correspondence
Oct 06, 2022

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 12, 2022

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 07, 2022

Major Issues Report

Form 8-K - Current report
Aug 15, 2022

Major Issues Report

Form 8-K - Current report
Jun 16, 2021

Major Issues Report

8-K - Current report
Jun 14, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 03, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 03, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 25, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 19, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 10, 2021

Major Issues Report

8-K - Current report
May 07, 2021

Major Issues Report

8-K - Current report
May 07, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]